HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.

Abstract
The T lymphocyte antigens, which may have a role in protection against tularemia, were predicted by immunoinformatics analysis of Francisella tularensis Schu4. Twenty-seven class II putative promiscuous epitopes and 125 putative class I supertype epitopes were chosen for synthesis; peptides were tested in vitro for their ability to bind HLA and to induce immune responses from PBMCs of 23 previously infected subjects. While the immune responses of individual subjects showed heterogeneity, 95% of the subjects responded strongly to a pool of 27 promiscuous peptides; 25%, 33%, and 44% of subjects responded to pools of 25 A2, A24, and B7 peptides, respectively. These data can aid in the development of novel epitope-based and subunit tularemia vaccines.
AuthorsJulie A McMurry, Stephen H Gregory, Leonard Moise, Daniel Rivera, Soren Buus, Anne S De Groot
JournalVaccine (Vaccine) Vol. 25 Issue 16 Pg. 3179-91 (Apr 20 2007) ISSN: 0264-410X [Print] Netherlands
PMID17291638 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antigens, Bacterial
  • Bacterial Vaccines
  • Epitopes
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Bacterial (administration & dosage, immunology)
  • Bacterial Vaccines (administration & dosage)
  • Drug Design
  • Epitopes (immunology)
  • Female
  • Francisella tularensis (chemistry, immunology)
  • Genes, MHC Class II (genetics)
  • Humans
  • Male
  • Middle Aged
  • T-Lymphocytes (immunology)
  • Tularemia (immunology, prevention & control)
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: